Cytonus Therapeutics has spun out of UC San Diego to develop cell-based containers for the effective release of therapeutics including cancer drugs.

US-based cancer drug delivery spinout Cytonus Therapeutics made its official debut today on the back of University of California (UC), San Diego research into using cells to release drugs into the body.
Founded in 2018, Cytonus Therapeutics is advancing cell-based drug delivery containers known as cargocytes intended to carry curative payloads including small molecules, gene therapies and antibodies to their target.
The cargocytes consist of allogenic cell lines engineered for a range of therapeutic applications, though Cytonus Therapeutics’…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?